Medical Design Technology -
26 Feb 2018 19:43
News A new variant of the gene-editing CRISPR/Cas9 system is safer and more specific than versions previously used in early research towards a treatment for Huntington's disease, shows ... Contributed Author: Frontiers
Share this Article